Effects of mirabegron on depression, anxiety, learning and memory in mice
Abstract Mirabegron is the first b3-adrenoceptor agonist to enter clinical practice and has been approved for the treatment of symptoms of OAB. The aim of this study is to investigate whether the mirabegron has an effect on depression, anxiety, learning, and memory. We investigated the effects of mi...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Academia Brasileira de Ciências
2021-12-01
|
| Collection: | Anais da Academia Brasileira de Ciências |
| Sujets: | |
| Accès en ligne: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652021000800703&tlng=en |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|